StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Abbvie (ABBV) PT Lowered to $187 at Barclays
April 29, 2024 5:22 AM
Barclays analyst Carter Gould lowered the price target on ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Form 8-K AbbVie Inc. For: Apr 26
April 26, 2024 10:43 AM
AbbVie Reports First-Quarter 2024 Financial Results
April 26, 2024 10:42 AM
Drugmaker AbbVie expects Humira volume erosion to worsen
April 26, 2024 7:44 AM
AbbVie (ABBV) hikes 2024 earnings guidance as Q1 beat estimates, shares up
April 26, 2024 7:42 AM
AbbVie (ABBV) Tops Q1 EPS by 4c, Raises Guidance
April 26, 2024 7:36 AM
AbbVie (ABBV) April weekly option implied volatility into quarter results
April 25, 2024 10:19 AM
AbbVie (ABBV): New Data Show RINVOQ Demonstrated Superiority Versus DUPIXENT Across Primary and All Secondary Endpoints
April 25, 2024 8:29 AM
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
April 25, 2024 8:00 AM
AbbVie (ABBV) April weekly 167.50 straddle into quarter results
April 25, 2024 5:22 AM
